Senior Catalent Executives Invited to Give Expert Opinion on Drug Development and Partnering Strategies at Upcoming Pharma Integrates Conference

Share Article

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, today announced that Sharon Johnson, Senior Vice President Quality Product Development & Regulatory Affairs, and Cornell Stamoran, Vice President Corporate Strategy, have been invited to join panels of leading industry experts at the upcoming Pharma Integrates conference, to be held at the Grange City Hotel, London, UK, on November 17th – 18th, 2015.

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, today announced that Sharon Johnson, Senior Vice President Quality Product Development & Regulatory Affairs, and Cornell Stamoran, Vice President Corporate Strategy, have been invited to join panels of leading industry experts at the upcoming Pharma Integrates conference, to be held at the Grange City Hotel, London, UK, on November 17th – 18th, 2015.

The conference, now in its fourth year, brings together representatives from across the global pharmaceutical industry and this year has a focus on strategic relationships throughout its agenda.

Dr. Stamoran will join a panel at 3.50 p.m., on Tuesday, November 17th, alongside representatives from Pfizer, Corden Pharma and UCB Pharma, to discuss “Optimizing the Product-Performance Model;” and Ms. Johnson’s session, at 9.00 a.m., on Wednesday, November 18th, is entitled “Accelerating Product Development: From Innovation to Commercialisation”, where she will be joined on a panel by executives from Sanofi, CANbridge, the European Medicines Agency, and the University of Cambridge.

For more information on the Pharma Integrates conference, visit: http://www.lifesciencesindex.com/pharma-integrates-2015 and to arrange a meeting with Catalent executives at the conference, please contact Richard Kerns at NEPR – richard(at)nepr.eu.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Halling

Richard Kerns
Northern Exposure PR
+44 7974 579202
Email >
Visit website